News in brief: Imported Ig available now; Test for COVID vaccine-related thrombosis; Haematologist develops novel treatment for CNS lymphoma

Expanded choice of immunoglobulins Imported immunoglobulin products Octagam (10% concentration IVIg) and Cuvitru (20% concentration SCIg) have come onto the Australian market this month. Contracts are also in place for two other imported products Kiovig (IVIg) and Hyqvia (SCIg) to follow. The National Blood Authority said current products – Gamunex, Flebogamma, Privigen and Hizentra – ...

Already a member?

Login to keep reading.

© 2021 the limbic